Cargando…

ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy

INTRODUCTION: The efficacy of postoperative radiotherapy (PORT) is still unclear in non-small cell lung cancer (NSCLC) patients with pIIIA-N2 disease. Estrogen receptor (ER) was proven significantly associated with poor clinical outcome of male lung squamous cell cancer (LUSC) after R0 resection in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xue, Wang, Lili, Jin, Xiangfeng, Xu, Rongjian, Yu, Zhuang, Li, Hongmei, Lu, Haijun, An, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176091/ https://www.ncbi.nlm.nih.gov/pubmed/37188197 http://dx.doi.org/10.3389/fonc.2023.1158104

Ejemplares similares

ER expression associates with poor prognosis in male lung squamous carcinoma after radical resection
por: Yang, Xue, et al.
Publicado: (2021)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
por: He, Wenwu, et al.
Publicado: (2021)

Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma
por: JINNO, TEPPEI, et al.
Publicado: (2015)

Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2016)

Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis
por: Xi, Junjie, et al.
Publicado: (2020)

Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
por: Chiu, Tai-Jan, et al.
Publicado: (2018)

Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma
por: El-Hadaad, Hend Ahmed, et al.
Publicado: (2012)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma
por: Tong, Yu-suo, et al.
Publicado: (2014)

SDF-1α predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients
por: Lu, Siyi, et al.
Publicado: (2021)

Sequential Chemoradiotherapy Compared to Radiotherapy in Endometrial Carcinoma
por: Elemam, Omima, et al.
Publicado: (2020)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
por: Yap, Wing-Keen, et al.
Publicado: (2022)

ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma
por: Ma, Xiao-Li, et al.
Publicado: (2019)

Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
por: Wallerek, Sandra, et al.
Publicado: (2015)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
por: Ikawa, Toshiki, et al.
Publicado: (2019)

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022)

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma
por: Shimada, H, et al.
Publicado: (2002)

Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy
por: Qian, Junchao, et al.
Publicado: (2022)

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
por: Marchetti, Antonio, et al.
Publicado: (2022)

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
por: Ismaili, Nabil, et al.
Publicado: (2009)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer after surgery
por: Ma, Wenyan, et al.
Publicado: (2023)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022)

The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2023)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Ionic liquids IIIA
por: Rogers, Robin D, et al.
Publicado: (2005)

Increased Expression of Lin28B Associates with Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
por: Wu, Tianfu, et al.
Publicado: (2013)

KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients
por: Duan, Hao, et al.
Publicado: (2016)

FNDC3B is associated with ER stress and poor prognosis in cervical cancer
por: Han, Bing, et al.
Publicado: (2020)

Real world clinical outcomes of adjuvant sequential chemoradiation in patients with gallbladder carcinomas with poor performance status
por: Kapoor, Rakesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kdijnc1e9qnpvt0kt7upp699fc